Cryptorchidism Differential Diagnosis: A Comprehensive Guide for Automotive Technicians

Introduction

Cryptorchidism, also known as undescended testes, is a prevalent congenital condition in male infants, characterized by the absence of one or both testicles from the scrotum. Affecting approximately 3% of full-term and up to 30% of premature male newborns, understanding cryptorchidism is crucial for healthcare professionals. While seemingly unrelated to automotive repair, as content creators for xentrydiagnosis.store, a website for auto repair experts, recognizing medical conditions, especially those that may impact future generations, aligns with our commitment to providing comprehensive and valuable information to our audience. Untreated cryptorchidism can lead to significant long-term health issues, including fertility problems, increased risk of testicular cancer, testicular torsion, inguinal hernias, and psychological distress. Therefore, accurate diagnosis, particularly the Cryptorchidism Differential Diagnosis, and timely management are paramount. Clinicians rely on palpation to locate undescended testicles, often found in the inguinal canal, abdomen, or even absent. Surgical correction, orchiopexy, is typically recommended if the testis does not descend by 6 months of age to mitigate potential complications.

This article aims to provide a detailed overview of cryptorchidism, focusing on its differential diagnosis, management, and long-term implications. While our primary audience is automotive technicians, understanding health conditions indirectly related to family well-being enhances our holistic approach to content creation. We will explore diagnostic techniques, including palpation, imaging, and hormonal assessments, enabling accurate identification and localization of undescended testicles. Furthermore, we will discuss effective counseling strategies for families, ensuring they are well-informed and supported in making treatment decisions and planning long-term care for their children. A multidisciplinary approach to cryptorchidism management, emphasizing collaboration among urologists, pediatric surgeons, endocrinologists, and primary care physicians, will also be highlighted.

Etiology of Cryptorchidism

A properly functioning hypothalamic-pituitary-gonadal axis is essential for normal testicular descent, orchestrating the hormonal signals necessary for this developmental process. While the appendix testis’s exact role remains unclear, its absence has been linked to abdominal and cryptorchid testes, particularly those located near the external ring.

In many full-term infants, the exact cause of cryptorchidism remains undetermined, classifying it as a common yet sporadic idiopathic congenital anomaly. Experts suggest that a combination of genetic predisposition, maternal factors, and environmental influences may disrupt the hormonal and physical mechanisms governing testicular development and descent.

Lower birth weight is a significant risk factor for undescended testes, followed by a family history of the condition. Additional risk factors include:

• Maternal alcohol consumption during pregnancy (5+ drinks/week)
• Exposure to endocrine-disrupting chemicals
• Maternal cigarette smoking
• Congenital malformation syndromes (Down syndrome, Prader–Willi syndrome, Noonan syndrome)
• Maternal use of cosmetics
• Phthalate exposure (DEHP)
• Family history of cryptorchidism
• Maternal ibuprofen use
• In vitro fertilization
• Maternal diabetes
• Maternal exposure to diethylstilbestrol
• Maternal obesity
• Persistent Müllerian duct syndrome
• Pesticide exposure
• Preeclampsia
• Prematurity
• Small for gestational age
• Smaller placental weight

Epidemiology of Cryptorchidism

Cryptorchidism is observed in approximately 3% of full-term newborns, decreasing to about 1% by 6 months to 1 year of age. In the United States, prevalence ranges from around 3% at birth to 1% from one year into adulthood. Globally, prevalence varies, starting at 4-5% at birth, decreasing to 1-1.5% at 3 months, and 1-2.5% at 9 months. Premature male neonates exhibit a significantly higher prevalence of 30%. This elevated rate underscores the necessity for vigilant monitoring of testicular development and timely intervention.

Family history plays a role, with cryptorchidism affecting approximately 1.5% to 4% of fathers and 6% of brothers of affected individuals. Heritability among first-degree male relatives is estimated at 0.5% to 1%. Furthermore, 7% of siblings of boys with undescended testes also have cryptorchidism, highlighting a potential genetic predisposition. Research continues to investigate a possible link between cryptorchidism and autism.

Pathophysiology of Cryptorchidism

The scrotal environment is crucial for optimal testicular function, maintaining a cooler temperature essential for sperm production. In cryptorchidism, the altered microenvironment of the abdominal cavity or inguinal canal, with its higher temperature, disrupts these optimal conditions. Elevated temperature in these ectopic locations can impair sperm development and negatively affect fertility.

Cryptorchidism can also disrupt communication between the testes and the endocrine system, potentially causing transient hormonal deficiencies. These hormonal imbalances may contribute to failed testicular descent and hinder spermatogenic tissue development, further compromising fertility.

History and Physical Examination in Cryptorchidism

The most obvious clinical sign of cryptorchidism is the absence of a palpable testicle in the scrotum. Often, an inguinal hernia and reduced scrotal rugae (ridges) are also present. A thorough physical examination of the entire inguinal and pelvic area, including assessment of the contralateral testicle, is essential. If the scrotum exhibits normal rugae and contains a testicle, a retractile testicle should be considered, which typically does not require treatment. However, patients with cryptorchidism may present with other associated signs and symptoms, including:

Infertility: Hyperthermia, anatomical abnormalities like testis-epididymal dissociation, and potential injury to the vas deferens, epididymis, or testis during orchiopexy can contribute to reduced fertility in individuals with cryptorchidism. Higher rates of anti-sperm antibodies are also observed in infertile patients with a history of cryptorchidism. Even after orchiopexy, fertility may remain diminished, particularly in bilateral cases. Early surgical intervention is universally recommended as untreated undescended testes can suffer spermatogenic tissue degeneration and reduced spermatogonia after the second year of life.

Psychological Consequences: While boys with undescended testicles are not inherently predisposed to gender identity issues, detrimental family dynamics can negatively impact self-esteem and self-image. Surgical correction of cryptorchidism can positively contribute to the development of a healthy sense of masculinity.

Cancer: The risk of testicular cancer is significantly elevated in undescended testes. Orchiopexy performed before puberty reduces this risk but it still remains higher than in the general population. Seminoma is the most common type of testicular cancer in untreated undescended testes. Testicular self-examination education is crucial for boys who have undergone orchiopexy to facilitate early cancer detection.

Evaluation of Cryptorchidism

According to the American Urological Association (AUA) guidelines, physical examination by an experienced provider can palpate over 70% of cryptorchid testes, negating the need for imaging. In the remaining 30% with nonpalpable testes, the diagnostic challenge is to confirm the testis’s presence or absence and determine the location of any viable nonpalpable testis.

Routine ultrasound has limited utility due to low sensitivity and specificity in locating nonpalpable testes. Computed tomography is restricted by cost and radiation concerns. Magnetic resonance imaging (MRI) offers higher sensitivity and specificity but is costly, has limited availability, and often requires anesthesia, making it less desirable as a first-line imaging modality. Currently, no radiological test definitively confirms testicular absence. Radiological tests often provide inconclusive or misleading information, rarely aiding in decision-making.

Karyotype analysis can rule out dysgenetic primary hypogonadism. Hormone levels (gonadotropins, Müllerian inhibitory substance) can confirm hormonally functional testes. Human chorionic gonadotropin (hCG) stimulation can elevate testosterone levels. Further testing may be necessary to detect intersex conditions.

Bilateral Cryptorchidism: Bilateral cryptorchidism with palpable testes is surgically correctable, although the optimal timing of bilateral orchiopexy is debated. Bilateral impalpable testes necessitate further evaluation to rule out disorders of sexual development. Circumcision should be deferred until evaluation is complete. In cases of bilateral impalpable testes, congenital adrenal hyperplasia should be excluded, involving electrolyte measurements, karyotype analysis, and hormonal profiling. After excluding congenital adrenal hyperplasia, assessing for testicular tissue is crucial, with anti-Müllerian hormone levels indicating the presence of testicular tissue. In cases with a male karyotype, bilateral nonpalpable testes, elevated FSH, and undetectable anti-Müllerian hormone and inhibin B, anorchia (absence of testes) can be reasonably diagnosed. Exploratory laparoscopy may be performed if testicular tissue is presumed present to determine location and surgical approach.

Treatment and Management of Cryptorchidism

Medical Treatment: Hormonal therapy to induce testicular descent is generally not recommended due to low success rates and lack of long-term efficacy, according to AUA guidelines and other international medical organizations. While hCG may be considered in specific cases like Prader-Willi syndrome to avoid general anesthesia risks, a meta-analysis indicates hormonal treatment is no more effective than placebo.

Surgery: Surgical orchiopexy is the recommended treatment for congenital undescended testes, ideally performed between 6 and 18 months of age, with many specialists advocating for surgery around 6 months to optimize testicular growth and fertility preservation. Delays in orchiopexy are common, with potential negative impacts on fertility and increased risks of testicular malignancy. Corrected age is used for premature infants to determine surgical timing. Early orchiopexy is the standard intervention, as prolonged cryptorchidism leads to germ cell loss and reduced fertility. Surgery is also promptly recommended for acquired and entrapped undescended testes. Annual physical exams are recommended for retractile testes due to the risk of them becoming acquired undescended testes.

Techniques of Orchiopexy: For palpable undescended testes, inguinal or scrotal orchiopexy is recommended. The procedure involves incision, cremasteric muscle division, hernia sac separation, and testicular fixation in the scrotum. For nonpalpable testes, exploratory laparoscopy is recommended. Laparoscopic orchiopexy options include vessel-preserving orchiopexy, single-stage Fowler-Stephens orchiopexy, two-stage Fowler-Stephens orchiopexy, and two-stage traction-orchidopexy (Shehata technique). The Shehata technique, a two-stage traction-orchidopexy, offers high success rates in relocating intra-abdominal testes without sacrificing testicular vessels and with a shorter delay compared to Fowler-Stephens procedures. Surgical approach selection depends on surgeon experience and preference. If no testis is found during laparoscopy, confirming blind-ending vessels or a testicular nubbin is crucial to rule out a missing testis.

Differential Diagnosis of Cryptorchidism

A key diagnostic challenge is differentiating a retractile testicle from a true undescended testicle. Retractile testes are more common and do not require surgery. Retractile testes are due to cremaster muscle contraction, causing the testicles to retract temporarily.

Distinguishing Retractile Testicle from Cryptorchidism: Differentiating a high scrotal retractile testicle from a low inguinal canal cryptorchid testicle can be difficult. Maneuvers to aid in cryptorchidism differential diagnosis include examining the patient in a cross-legged position, using soaped fingers, and examining in a warm bath to relax the cremasteric reflex. According to AUA guidelines, a retractile testis is initially outside the scrotum or easily moved out but can be manually placed and remain in a stable scrotal position without tension.

Conditions to consider in the cryptorchidism differential diagnosis include:

• Retractile Testicle: As described above, this is the most common condition to differentiate from cryptorchidism. The testicle can be manipulated into the scrotum and stays there temporarily without tension.
• Ectopic Testicle: The testicle has descended outside the normal pathway, often found in the superficial inguinal pouch, femoral triangle, or perineum. Palpation can usually identify an ectopic testicle outside the typical inguinal canal location.
• Ascending Testicle (Acquired Undescended Testicle): A testicle that was previously documented in the scrotum but has subsequently ascended. This condition requires prompt surgical referral.
• Anorchia (Congenital Absence of Testis): In bilateral nonpalpable cryptorchidism, especially with a 46, XY karyotype, anorchia should be considered. Hormonal evaluation (low AMH, high FSH) and potentially laparoscopy can aid in diagnosis.
• Vanishing Testis Syndrome: Similar to anorchia, but may involve testicular regression in utero, possibly leaving a testicular nubbin.
• Inguinal Hernia: Often co-exists with cryptorchidism and should be considered in the differential diagnosis, especially in cases presenting with inguinal swelling. However, inguinal hernia is usually an associated condition rather than a mimic.
• Hydrocele: While hydroceles are scrotal fluid collections and distinct from cryptorchidism, they can sometimes obscure palpation of the testes, making examination for cryptorchidism more challenging.
• Testicular Torsion: Presents with acute scrotal pain and swelling, a separate emergency condition, but must be considered if cryptorchidism is newly discovered in an older child or adolescent presenting with pain.

A careful history and thorough physical examination, focusing on palpation technique and understanding the characteristics of retractile vs. undescended testes, are crucial for accurate cryptorchidism differential diagnosis.

Prognosis of Cryptorchidism

With timely diagnosis and treatment, the prognosis for cryptorchidism is generally excellent. However, even with treatment, there remains a slightly elevated risk of testicular cancer and infertility compared to the general population. Studies indicate that men with a history of cryptorchidism may have reduced testicular volume, lower sperm concentration, and diminished Leydig cell function compared to those without cryptorchidism.

Complications of Orchiopexy

Orchiopexy, while generally safe, carries risks of testicular atrophy and testicular ascent, occurring in approximately 1% of palpable testis orchiopexies and around 5% of laparoscopic orchiopexies. Fowler-Stephens orchiopexy has a higher testicular atrophy rate (20-30%), particularly with the single-stage procedure. Over-skeletonization of the spermatic cord is a severe complication that can lead to testis loss.

Deterrence and Patient Education for Cryptorchidism

Physicians must carefully examine neonates for proper testicular placement, as spontaneous descent can occur within the first 6 months of life. Regular scrotal examinations by clinicians and parents are essential. Patient education should emphasize the nature of untreated cryptorchidism, the importance of early surgery, and the risks of delayed intervention.

Pearls and Other Issues in Cryptorchidism

Key points to remember about cryptorchidism:

• Birth weight and family history are major risk factors.
• Clinical signs include absent scrotal testicles, inguinal hernia, and reduced scrotal rugae.
• Differentiate undescended testes from retractile testes.
• Thorough inguinal and pelvic examination is crucial, including contralateral testicle assessment.
• Nonunion of epididymis and testicle can mimic testicular nubbin.
• Potential complications include infertility.
• Orchiopexy is the recommended treatment between 6 and 18 months.

Enhancing Healthcare Team Outcomes in Cryptorchidism Management

Awareness of optimal orchiopexy timing is crucial for all pediatric and family healthcare professionals to minimize risks of infertility and cancer. Effective collaboration and communication among physicians, nurse practitioners, physician assistants, pediatricians, and urological surgeons are essential for improved outcomes, reduced unnecessary procedures, and timely surgeries.

Review Questions (Original Article Link)

Access free multiple choice questions on this topic.

References (Same as Original Article)

1.Khatwa UA, Menon PS. Management of undescended testis. Indian J Pediatr. 2000 Jun;67(6):449-54. [PubMed: 10932966]
2.Shin J, Jeon GW. Comparison of diagnostic and treatment guidelines for undescended testis. Clin Exp Pediatr. 2020 Nov;63(11):415-421. [PMC free article: PMC7642136] [PubMed: 32252147]
3.Hadziselimovic F. On the descent of the epididymo-testicular unit, cryptorchidism, and prevention of infertility. Basic Clin Androl. 2017;27:21. [PMC free article: PMC5686796] [PubMed: 29163975]
4.Rodprasert W, Virtanen HE, Mäkelä JA, Toppari J. Hypogonadism and Cryptorchidism. Front Endocrinol (Lausanne). 2019;10:906. [PMC free article: PMC6974459] [PubMed: 32010061]
5.Urry RL, Carrell DT, Starr NT, Snow BW, Middleton RG. The incidence of antisperm antibodies in infertility patients with a history of cryptorchidism. J Urol. 1994 Feb;151(2):381-3. [PubMed: 7904310]
6.Sinisi AA, Pasquali D, Papparella A, Valente A, Orio F, Esposito D, Cobellis G, Cuomo A, Angelone G, Martone A, Fioretti GP, Bellastella A. Antisperm antibodies in cryptorchidism before and after surgery. J Urol. 1998 Nov;160(5):1834-7. [PubMed: 9783970]
7.Braga LH, Lorenzo AJ, Romao RLP. Canadian Urological Association-Pediatric Urologists of Canada (CUA-PUC) guideline for the diagnosis, management, and followup of cryptorchidism. Can Urol Assoc J. 2017 Jul;11(7):E251-E260. [PMC free article: PMC5519382] [PubMed: 28761584]
8.Kolon TF, Herndon CD, Baker LA, Baskin LS, Baxter CG, Cheng EY, Diaz M, Lee PA, Seashore CJ, Tasian GE, Barthold JS., American Urological Assocation. Evaluation and treatment of cryptorchidism: AUA guideline. J Urol. 2014 Aug;192(2):337-45. [PubMed: 24857650]
9.Tasian GE, Copp HL. Diagnostic performance of ultrasound in nonpalpable cryptorchidism: a systematic review and meta-analysis. Pediatrics. 2011 Jan;127(1):119-28. [PMC free article: PMC3010084] [PubMed: 21149435]
10.Krishnaswami S, Fonnesbeck C, Penson D, McPheeters ML. Magnetic resonance imaging for locating nonpalpable undescended testicles: a meta-analysis. Pediatrics. 2013 Jun;131(6):e1908-16. [PMC free article: PMC4074662] [PubMed: 23690512]
11.Berger C, Haid B, Becker T, Koen M, Roesch J, Oswald J. Nonpalpable testes: Ultrasound and contralateral testicular hypertrophy predict the surgical access, avoiding unnecessary laparoscopy. J Pediatr Urol. 2018 Apr;14(2):163.e1-163.e7. [PubMed: 29199091]
12.Niedzielski JK, Oszukowska E, Słowikowska-Hilczer J. Undescended testis – current trends and guidelines: a review of the literature. Arch Med Sci. 2016 Jun 01;12(3):667-77. [PMC free article: PMC4889701] [PubMed: 27279862]
13.Berkowitz GS, Lapinski RH, Dolgin SE, Gazella JG, Bodian CA, Holzman IR. Prevalence and natural history of cryptorchidism. Pediatrics. 1993 Jul;92(1):44-9. [PubMed: 8100060]
14.Kurz D. Current Management of Undescended Testes. Curr Treat Options Pediatr. 2016 Mar;2(1):43-51. [PMC free article: PMC4856300] [PubMed: 27158583]
15.Misra M, MacLaughlin DT, Donahoe PK, Lee MM. Measurement of Mullerian inhibiting substance facilitates management of boys with microphallus and cryptorchidism. J Clin Endocrinol Metab. 2002 Aug;87(8):3598-602. [PubMed: 12161481]
16.Wei Y, Wang Y, Tang X, Liu B, Shen L, Long C, Lin T, He D, Wu S, Wei G. Efficacy and safety of human chorionic gonadotropin for treatment of cryptorchidism: A meta-analysis of randomised controlled trials. J Paediatr Child Health. 2018 Aug;54(8):900-906. [PubMed: 29655188]
17.Radmayr C, Dogan HS, Hoebeke P, Kocvara R, Nijman R, Silay S, Stein R, Undre S, Tekgul S. Management of undescended testes: European Association of Urology/European Society for Paediatric Urology Guidelines. J Pediatr Urol. 2016 Dec;12(6):335-343. [PubMed: 27687532]
18.Kim JK, Chua ME, Ming JM, Santos JD, Zani-Ruttenstock E, Marson A, Bayley M, Koyle MA. A critical review of recent clinical practice guidelines on management of cryptorchidism. J Pediatr Surg. 2018 Oct;53(10):2041-2047. [PubMed: 29269095]
19.Williams K, Baumann L, Shah A, Abdullah F, Johnson EK, Oyetunji TA. Age at orchiopexy for undescended testis in the United States. J Pediatr Surg. 2017 Oct 12; [PubMed: 29102151]
20.Schneuer FJ, Milne E, Jamieson SE, Pereira G, Hansen M, Barker A, Holland AJA, Bower C, Nassar N. Association between male genital anomalies and adult male reproductive disorders: a population-based data linkage study spanning more than 40 years. Lancet Child Adolesc Health. 2018 Oct;2(10):736-743. [PubMed: 30236382]
21.Yiee JH, Saigal CS, Lai J, Copp HL, Churchill BM, Litwin MS., Urologic Diseases in America Project. Timing of orchiopexy in the United States: a quality-of-care indicator. Urology. 2012 Nov;80(5):1121-6. [PMC free article: PMC3753094] [PubMed: 23107402]
22.Jiang DD, Acevedo AM, Bayne A, Austin JC, Seideman CA. Factors associated with delay in undescended testis referral. J Pediatr Urol. 2019 Aug;15(4):380.e1-380.e6. [PubMed: 31072764]
23.Thorup J, Cortes D. Surgical Management of Undescended Testis – Timetable and Outcome: A Debate. Sex Dev. 2019;13(1):11-19. [PubMed: 30685766]
24.Shehata S, Shalaby R, Ismail M, Abouheba M, Elrouby A. Staged laparoscopic traction-orchiopexy for intraabdominal testis (Shehata technique): Stretching the limits for preservation of testicular vasculature. J Pediatr Surg. 2016 Feb;51(2):211-5. [PubMed: 26655212]
25.Abouheba MAS, Younis W, Elsokary A, Roshdy W, Waheeb S. Early Clinical Outcome of Staged Laparoscopic Traction Orchidopexy for Abdominal Testes. J Laparoendosc Adv Surg Tech A. 2019 Apr;29(4):531-537. [PubMed: 30807243]
26.Niedzielski J, Balinska K, Wilk D, Slowikowska-Hilczer J. The effect of the two-stage laparoscopic Fowler-Stevens operation on testicular growth and risk of atrophy in boys with intra-abdominal testes. Arch Med Sci. 2022;18(3):666-671. [PMC free article: PMC9102531] [PubMed: 35591847]
27.Shehata SM. Laparoscopically assisted gradual controlled traction on the testicular vessels: a new concept in the management of abdominal testis. A preliminary report. Eur J Pediatr Surg. 2008 Dec;18(6):402-6. [PubMed: 19012232]
28.Liu J, Tang R, Wang X, Sui B, Jin Z, Xu X, Zhu Q, Chen J, Ma H, Duan G. Comparison of Two Types of Staged Laparoscopic Orchiopexy for High Intra-Abdominal Testes in Children: A Retrospective Study From a Single Center. Front Pediatr. 2021;9:677955. [PMC free article: PMC8247650] [PubMed: 34222147]
29.Tian Q, Zhao X, Zhang C, Yu K, Fang E, Zhou X, Yuan J, Li N. Compared outcomes of high-level cryptorchidism managed by Fowler-Stephens orchiopexy versus the Shehata technique: A systematic review and meta-analysis. J Pediatr Urol. 2023 Jun;19(3):313-319. [PubMed: 36966014]
30.Cheng L, Albers P, Berney DM, Feldman DR, Daugaard G, Gilligan T, Looijenga LHJ. Testicular cancer. Nat Rev Dis Primers. 2018 Oct 05;4(1):29. [PubMed: 30291251]
31.Koch T, Hansen AH, Priskorn L, Petersen JH, Carlsen E, Main KM, Skakkebaek NE, Jørgensen N. A history of cryptorchidism is associated with impaired testicular function in early adulthood: a cross-sectional study of 6376 men from the general population. Hum Reprod. 2020 Aug 01;35(8):1765-1780. [PubMed: 32728685]
32.Elyas R, Guerra LA, Pike J, DeCarli C, Betolli M, Bass J, Chou S, Sweeney B, Rubin S, Barrowman N, Moher D, Leonard M. Is staging beneficial for Fowler-Stephens orchiopexy? A systematic review. J Urol. 2010 May;183(5):2012-8. [PubMed: 20303527]
33.Yağız B, Kara YA, Hancıoğlu S, Demirel BD, Karaman A, Bıçakcı Ü, Arda N, Karaman İ. Sentinel nubbin: A potential pitfall in the management of undescended testis secondary to epididymo-testicular nonunion. J Pediatr Urol. 2020 Oct;16(5):635.e1-635.e7. [PubMed: 32891575]